A real-world experience of venetoclax combined with hypomethylating agents vs. monotherapy hypomethylating agents in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia patients

• 主要な著者: Ludan Zhang (著者), Rui Ge (著者), Deng Pan (著者), Pengjie Yue (著者), Jingwen Zhang (著者), Renjie Bian (著者), Xiaojing Yan (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2024-05-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Introduction:Current clinical research has reported the effectiveness and safety of venetoclax in combination with hypomethylating agents (VEN-HMA) in patients with myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML). Thus, this study aimed to examine the effectiveness and saf...